Browsing Tag

Formulation/Drug Product Manufacturing

318 posts

WuXi To Build US Facility; Sharp, Catalent Acquire Packaging Facilities
By

By
The latest news from CDMOs, CMOs, and suppliers featuring WuXi Advanced Therapies, WuXi Biologics, Catalent, Sharp, Colorcon, and Rentschler Biopharma. Biologics Manufacturing WuXi Biologics To Build New Biomanufacturing Facility in…

MilliporeSigma Launches Bioprocessing Suite; Evonik Expands
By

By
The latest news from CDMOs, CMOs, and suppliers featuring MilliporeSigma, Evonik, Marken, Ori Biotech and CellGenix. Biologics Manufacturing MilliporeSigma Launches Next Tool of Bioprocessing Software Suite Millipore Sigma has launched…

CDMO, CMO, Supplier Roundup in Supporting COVID-19 Projects
By

By
The latest from CDMOs, CMOs, and suppliers in COVID-19 projects featuring Catalent, Sterling Pharma, ABL, and  Singota. Chemicals/Chemical API Manufacturing Sterling Begins Hydroxychloroquine Production in the UKSterling Pharma Solutions, a Dudley, UK-headquartered CDMO,…

CDMO, CMO, Supplier Roundup in Supporting COVID-19 Projects
By

By
The latest from CDMOs and suppliers in COVID-19 efforts featuring Seqens, Catalent, MilliporeSigma, Recipharm, Fujifilm Diosynth, AMRI, and Ajinomoto Bio-Pharma. Chemicals/Chemical API Manufacturing Seqens Supports Potential COVID-19 TreatmentSeqens, a CDMO of…

Seqens To Expand Flow-Chemistry Capabilities; Adare Acquires Orbis Biosciences
By

By
The latest news from CDMOs, CMOs, and suppliers featuring Seqens, Adare Pharmaceuticals, AGC Biologics, Avid Bioservices, Avantor, Kindeva, and Univercells. Chemicals/Chemical API Manufacturing Seqens To Expand Flow-Chemistry CapabilitiesSeqens is adding…

CDMO/CMO and Supplier Roundup in Supporting COVID-19 Projects
By

By
The latest from CDMOs, CMOs, and suppliers in COVID-19 efforts featuring Ology Bioservices, Univercells, AGC Biologics, Cytovance, and LabVantage. Biologics Manufacturing DOD Awards Ology Bioservices $27.3 M for Cell Platform Development…

WuXi Acquires Drug-Product Plant; Catalent Expands; Stevanato in Pact
By

By
The latest news from CDMOs, CMOs, and suppliers featuring WuXi Biologics, Catalent, Stevanato, Wasdell, and Evotec. Chemicals/Chemical API Manufacturing Evotec, leon-nanodrugs Enter Pact for Nanomedicine Evotec, a Hamburg, Germany-based drug-discovery…

Univercells Launches New CDMO; Xellia, Aphena, Cambrex Expand
By

By
The latest news from CDMOs, CMOs, and suppliers featuring news from Univercells, Xellia, Aphena, and Cambrex.  Biologics Manufacturing Univercells Launches CDMO Exothera Univercells, a technology company specializing in bioprocessing, has…

CDMO, CMO, Supplier COVID-19 Developments: Partnering and Operations
By

By
The latest from CDMOs, CMOs, and suppliers on supporting COVID-19 efforts featuring Cobra Biologics, Emergent Biosolutions, WuXi AppTec, Almac and Eurofins. Biologics manufacturing Cobra Biologics To Develop COVID-19 Vaccine Cobra…

Thermo Fisher Is Investing $475 M To Expand Capacity and Capabilities
By

By
Thermo Fisher Scientific is investing more than $475 million in commercial capabilities and capacity in 2020 for biologics, cell and gene therapies, and drug products. This investment, in addition to those…